Ausgabe 5/2013
Inhalt (8 Artikel)
Ciclosporin Use During Pregnancy
Karolina Paziana, Magaly Del Monaco, Elyce Cardonick, Michael Moritz, Matthew Keller, Bruce Smith, Lisa Coscia, Vincent Armenti
Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
Rashmi R. Shah, Joel Morganroth, Devron R. Shah
Strategies to Improve Adverse Drug Reaction Reporting: A Critical and Systematic Review
Cristian Gonzalez-Gonzalez, Elena Lopez-Gonzalez, Maria T. Herdeiro, Adolfo Figueiras
Ischaemic Colitis in Rheumatoid Arthritis Patients Receiving Tumour Necrosis Factor-α Inhibitors: An Analysis of Reports to the US FDA Adverse Event Reporting System
Allison Salk, Derrick J. Stobaugh, Parakkal Deepak, Eli D. Ehrenpreis
Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project
June M. McKoy, Matthew J. Fisher, D. Mark Courtney, Dennis W. Raisch, Beatrice J. Edwards, Marc H. Scheetz, Steven M. Belknap, Steven M. Trifilio, Athena T. Samaras, Dustin B. Liebling, Beatrice Nardone, Katrina Marie Tulas, Dennis P. West
Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso
Lassane Kabore, Pascal Millet, Souleymane Fofana, Driss Berdai, Caroline Adam, Françoise Haramburu
Effects of Maternal Epilepsy and Antiepileptic Drug Use during Pregnancy on Perinatal Health in Offspring: Nationwide, Retrospective Cohort Study in Finland
Miia Artama, Mika Gissler, Heli Malm, Annukka Ritvanen
The Development and Evaluation of Triage Algorithms for Early Discovery of Adverse Drug Interactions
Johanna Strandell, Ola Caster, Johan Hopstadius, I. Ralph Edwards, G. Niklas Norén